Longeveron Inc.

Biotech Miami, FL

About

Issuer

Entity type
Corporation
Jurisdiction
Delaware
Sector
Biotech
Headquarters
Miami, FL
Street
1951 Nw 7th Avenue
Zip
33136

Offering

Total offering
$33.5M
Amount sold
$15.9M
First sale
Mar 11, 2026
Min investment
$0
Securities
Equity, Other
Federal exemption
Rule 506(b)
Investors so far
7

How this filing compares

Ranked #3 of 23 Biotech filings in March 2026 by offering amount.

Median Biotech filing in March 2026: $5.4M. This offering is 6.2× the median.

Other Florida filings this week: 4491 STATE RD 7 HOLDINGS LLLP, American Ventures LLC, Series XIII SKBL III, Bee Ridge Storage Associates, LLC, Cool Capital Holdings LP, Good Alpha Industries Series LLC, Tranche VI

Leadership

Stephen H. Willard — Executive Officer

Joshua M. Hare — Executive Officer (also: Director)

Lisa A. Locklear — Executive Officer

Nataliya Agafonova — Executive Officer

Paul Lehr — Executive Officer

Devin Blass — Executive Officer

Rock Soffer — Director

Ursula Ungaro — Director

Roger Joseph Hajjar — Director

George Paletta, Jr. — Director

Filing details

Longeveron Inc. filed a Form D with the SEC on March 25, 2026.

Other newest Biotech companies

Other newest companies in Florida